Retina Foundation of the Southwest

02/11/2024

01/29/2024

As experts and world-class leaders in their field, our physicians and researchers are often asked to present their work to help educate others in the industry. Dr. Srinivasa Sripathi, Director of the Henderson Ocular Stem Cell Laboratory, shared his latest research on age-related macular degeneration ( ) at UT Southwestern Medical Center. He was joined by Diane Boddy, who is participating in a groundbreaking study with Dr. Sripathi focused on genetics and . What a great way to kick off the New Year!

01/23/2024

We are honored that the Retina Foundation has been named as an official Spoke for the Advanced Research Projects Agency for Health (ARPA-H) Customer Experience Hub. This important designation enables our world-renowned team of retinal disease experts to work alongside others in the ARPA-H network to accelerate healthcare solutions for patients across the country. As the global medical destination for retinal disease research, we look forward to collaborating and sharing how the Retina Foundation’s unique environment allows for streamlined clinical trials to advance new solutions and treatments for those experiencing vision loss.

12/31/2023

www.retinafoundation.org Unwavering in our mission to prevent vision loss and restore sight through innovative research and treatment.

12/29/2023

www.retinafoundation.org

Unwavering in our mission to prevent vision loss and restore sight through innovative research and treatment.

12/26/2023

Unwavering in our mission to prevent vision loss and restore sight through innovative research and treatment.

www.retinafoundation.org

12/22/2023

www.retinafoundation.org Unwavering in our mission to prevent vision loss and restore sight through innovative research and treatment.

12/01/2023

11/30/2023

Follow the link below to view our November Newsletter!

https://conta.cc/3SZrqs4

11/28/2023

Your support will help more patients receive treatments to prevent vision loss and restore sight. https://retinafoundation.org/givingtuesday2023/?utm_source=Constant-Contact&utm_medium=eappeal&utm_campaign=GT2023

11/27/2023

Choose the Retina Foundation as your charity of choice this – November 28. Current studies in our Crystal Charity Ball Pediatric Vision Lab are focused on treatments for amblyopia and strabismus that treat the whole-child because these conditions don't just affect the eyes. Our research shows that reading, motor skills, and self-perception can all be challenged when even just one eye has impaired vision. Your support will help more patients receive treatments to prevent vision loss and restore sight. Make your early donation now. https://retinafoundation.org/givingtuesday2023/?utm_source=Constant-Contact&utm_medium=eappeal&utm_campaign=GT2023

11/24/2023

Choose the Retina Foundation as your charity of choice this – November 28. The Retina Foundation provided evidence that DHA enriched baby formula improves infant brain and eye development. Our research also showed that removing congenital cataracts within 2 weeks of birth gives the best chance at developing normal vision. The Retina Foundation has provided many with the best start for healthy vision. Give your Holiday Season the best start by giving early. https://retinafoundation.org/givingtuesday2023/?utm_source=Constant-Contact&utm_medium=eappeal&utm_campaign=GT2023

11/23/2023

11/22/2023

is coming on November 28! We hope you will choose the Retina Foundation as your charity of choice. Your gift will help us provide comprehensive exams, genetic testing and counselling and support programs such as our Southwest Eye Registry that greatly improves clinical trials. Don’t want to wait? Give your early donation now:

11/20/2023

Mark Pennesi, MD, PhD, FARVO, joins the Retina Foundation of the Southwest as Director of Ophthalmic Genetics, coming from the Casey Eye Institute in Portland. One of the nation’s experts in inherited retinal diseases (IRD), Dr. Pennesi brings his groundbreaking research to Dallas with a focus on expanding clinical trials to include more patients nationwide. Trials targeting these rare ocular diseases, such as retinitis pigmentosa and Stargardt disease, spotlight gene editing and gene therapy to find new solutions and treatments.

Dr. Pennesi earned a combined MD/PhD from the Baylor College of Medicine. He completed his residency at the University of California -San Francisco and an Ophthalmic Genetics fellowship at Casey Eye Institute. Dr. Pennesi served as the lead investigator for numerous first-in-human clinical trials for IRD, including the first trial to use CRISPR gene editing in humans. He serves on the executive committee for the Foundation Fighting Blindness Clinical Consortium.

11/06/2023

We are thrilled to announce that Naomi Emmett, MBA Emmett has joined the Retina Foundation as the new Chief Financial Officer and Chief Business Officer (CFO/CBO). With 15 years of experience overseeing financial matters and business functions for some of North Texas’ most esteemed universities, Naomi brings a wealth of expertise to our team.

Her extensive knowledge, financial prowess, and leadership skills make her a perfect fit for the Retina Foundation. We are confident her strategic vision and commitment to excellence will help guide our organization and elevate Retina Foundation as the leading medical destination for research solutions that could save or restore vision for millions.

We look forward to achieving great success with Naomi as an essential member of our leadership team. Here's to an exciting new chapter!

11/01/2023

👀Click here to see our 🎃👻October 2023 📧 Newsletter:

https://conta.cc/3tUhaGV

10/07/2023

You can also follow on Instagram to see more.

10/06/2023

Talented artist, Kathryn Ikle, knows firsthand how inherited retinal disease can impact a family. Her opening night reception will support the Retina Foundation's research to save sight!
Join us TONIGHT, Friday, October 6th from 6-8pm. The entire event is free to the public. There will be lots of refreshments, art and merch!

10/06/2023